Juan Carlos Ruiz Rodriguez Sóc metge adjunt del Servei de Medicina Intensiva de l'Hospital Universitari Vall d'Hebron. Les meves àrees d'interès són fonamentalment la sèpsia i la ressuscitació cardiopulmonar. Institutions of which they are part Main researcher Shock, Organ Dysfunction and Resuscitation Vall Hebron Institut de Recerca Intensive Care Medicine General Hospital Juan Carlos Ruiz Rodriguez Institutions of which they are part Main researcher Shock, Organ Dysfunction and Resuscitation Vall Hebron Institut de Recerca Intensive Care Medicine General Hospital Sóc metge adjunt del Servei de Medicina Intensiva de l'Hospital Universitari Vall d'Hebron. Les meves àrees d'interès són fonamentalment la sèpsia i la ressuscitació cardiopulmonar.
Especialista en Medicina Intensiva, vaig fer la residència en aquest hospital. Des que vaig acabar la residència sóc metge adjunt del Servei de Medicina Intensiva. També sóc coordinador del grup de recerca de Shock, Disfunció Orgànica i Ressuscitació del Vall d’Hebron Institut de Recerca i responsable de la línia de recerca de sèpsia. Les meves principals àrees d’interès són la sèpsia i la ressuscitació cardiopulmonar. Amb relació a la sèpsia, sóc el coordinador del Codi Sèpsia Intrahospitalari, coordinador del Comitè de Sèpsia, co-director del Banc de Sèpsia del Biobanc de l’Hospital i president del seu comitè científic. Amb relació a la ressuscitació cardiopulmonar sóc el president de la subcomissió d’aturada cardíaca de l’Hospital i responsable de la formació en suport vital dels professionals metges de l'hospital. Sóc professor associat de la Universitat Autònoma de Barcelona i director dels cursos de formació de suport vital de l'adult de l´hospital. Doctor en Medicina per la Universitat Autònoma de Barcelona.
Research lines Sepsis and Septic shock The objective of the sepsis research line is the study of biomarkers that allow the early identification of the septic patient as well as the prognostic stratification of these patients. For SODIR, the study of microbiological diagnosis from molecular identification studies is also extremely important. The research lines in sepsis and infectous diseases are currently working collaboratively with Microbiology Department in several research projects. Among them, we should specifically highlight the RAIS study (Scalable, point-of-care and label free microarray platform for rapid detection of Sepsis, H2020-ICT-2014-1, Grant Agreement no. 644956) financed by European Commission that has the objective of developing a platform that will allow the early identification of several inflammatory mediators of sepsis and some of the most frequent microorganisms associated with severe sepsis and septic shock. SODIR has created and developed the Sepsis Biobank in collaboration with de Microbiology Research Group of Vall d'Hebron University Hospital. The Sepsis Biobank of Vall d'Hebron University Hospital, co-directed by Juan Carlos Ruiz-Rodríguez, is a unit to support biomedical research that aims to make available to the scientific community samples of blood, plasma and serum of patients with sepsis and septic shock. The samples of Sepsis Biobank are obtained from septic patients with activation of the sepsis code of Vall d'Hebron University Hospital. The Sepsis Biobank, the first of Spain and the second of Europe, should be a tool to facilitate and promote biomedical research in sepsis in the scientific community. Currently two projects are already using samples of the BBS in their research. IP: Juan Carlos Ruiz Rodriguez Cardiac arrest and Life Suport The objective of research line of cardiac arrest and life support is to improve the knowledge about the inhospital cardiac arrest and to study more effective interventions during cardiac arrest and postresuscitation care that improve survival and life quality of the survived patients. SODIR also has a special interest in to identify the precipitating factors of the inhospital cardiac arrest and pericardiac arrest situations. IP: Juan Carlos Ruiz Rodriguez Acute respiratory failure The line of research in acute respiratory failure has special interest in the study of the involvement of the interleukin 33 and its ST2 receptor in acute lung injury and its role as a possible therapeutic target. A model of acute lung injury in mice has been designed to show the prognostic efficacy of interleukin 33 and ST-2 plasma levels. Currently, SODIR is evaluating the possibility that treatment with anti-IL-33 antibodies may decrease the degree of inflammation in a murine experimental model of acute lung injury. Another issue of special interest is the use of high flow nasal cannula supportive therapy. In this sense, SODIR has participated in a multicentric study, recently published in JAMA, analyzing the effect of high flow nasal cannula on postextubation respiratory failure. Finally, SODIR is also involved in several multicentric international trials about the use of esophageal pressure to guide mechanical ventilation settings in patients with acute respiratory distress syndrome. IP: Andres Francisco Pacheco Reyes, Juan Carlos Ruiz Rodriguez Critically ill patient monitoring The research line in critically ill patient monitoring, led by Dr.J.C.Ruiz, has as objectives the research in the application of echocardiography and other non-invasive or minimally invasive monitoring systems in the study of the pathophysiological mechanisms of the hemodynamic and cardiac dysfunction of the critical patient, and the study of microcirculation and its involvement in the pathophysiology of severe sepsis with multiorgan dysfunction. IP: Juan Carlos Ruiz Rodriguez Projects Capacidad predictiva de la "impresión subjetiva de la enfermera" en la detección del riesgo de deterioro agudo de los pacientes hospitalizados. IP: Sara López Branchadell Collaborators: Esperanza Zuriguel Pérez, Juan Carlos Ruiz Rodriguez, Patricia Rubio Garrido Funding agency: Col·legi Oficial d'Infermers/es de Barcelona Funding: 1749 Reference: PR-593/2023 Duration: 01/01/2024 - 31/12/2025 AMBROSIA: Multiplexed Plasmo-Photonic Biosensing Platform For Rapid And Intelligent Sepsis Diagnosis At The PointOf-Care IP: Juan Jose Gonzalez Lopez Collaborators: Juan Carlos Ruiz Rodriguez, AMBROSIA: Multiplexed Plasmo-Photonic Biosensing Platform For Rapid And Intelligent Sepsis Diagnosis At The PointOf-Care Funding agency: EUROPEAN COMMISSION Funding: 269812 Reference: AMBROSIA_HE-CL4_22_DIGI-EMERG01 Duration: 01/01/2023 - 31/12/2026 Development of a new intelligent and predictive tool for the early diagnosis and improved treatment of sepsis. IP: Juan Jose Gonzalez Lopez Collaborators: María Nieves Larrosa Escartin, Ricard Ferrer Roca, Juan Carlos Ruiz Rodriguez, Josep Roca Grande Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 339371 Reference: CPP2021-008464 Duration: 14/02/2022 - 30/09/2025 Shock, Disfunció Orgànica i Ressucitació IP: Ricard Ferrer Roca Collaborators: César Laborda Soriano, Alejandra García Roche, Candido Diaz Lagares, Rosa Maria Gracia Gozalo, Rosa Alcaraz Peñarrocha, Juan Carlos Ruiz Rodriguez, Xavier Nuvials Casals, Judith Sacanell Lacasa, Marcos Pérez Carrasco, José Alonso Fajardo, Adolfo Ruiz Sanmartin, Óscar Mula Castellón, Anna Sánchez Corral, Elisabeth Papiol Gallofré, Luis silvestre Chiscano Camon, Eduard Argudo Serra, Maria Martinez Martinez, Jordi Riera del Brío, Raquel Albertos Martell, Noemí Varga , Sofia Contreras Medina, Andres Francisco Pacheco Reyes, Manuel Roberto Sosa Garay, Camilo andres Bonilla Rojas, Manuel Roberto Sosa Garay Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 0.01 Reference: 2021 SGR 00798 Duration: 01/01/2022 - 30/06/2025 Pagination Current page 1 Page 2 Page 3 Next page › Last page »
